# Debbie S. Gipson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/debbie-s-gipson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,414 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 68 |
| i10-index | 178 |
| OpenAlex ID | https://openalex.org/A5054993212 |
| ORCID iD | 0000-0003-4473-9045 |
| Works | 306 |

## Researcher papers

Showing 12 of 20.

- [US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States](https://scholariq.org/papers/us-renal-data-system-2016-annual-data-report-epidemiology-of-kidney-disease-in/)
- [US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States](https://scholariq.org/papers/us-renal-data-system-2015-annual-data-report-epidemiology-of-kidney-disease-in/)
- [US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States](https://scholariq.org/papers/us-renal-data-system-2019-annual-data-report-epidemiology-of-kidney-disease-in/)
- [US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States](https://scholariq.org/papers/us-renal-data-system-2018-annual-data-report-epidemiology-of-kidney-disease-in/)
- [US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States](https://scholariq.org/papers/us-renal-data-system-2017-annual-data-report-epidemiology-of-kidney-disease-in/)
- [US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States](https://scholariq.org/papers/us-renal-data-system-2014-annual-data-report-epidemiology-of-kidney-disease-in/)
- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome](https://scholariq.org/papers/ipna-clinical-practice-recommendations-for-the-diagnosis-and-management-of/)
- [Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach](https://scholariq.org/papers/design-of-the-nephrotic-syndrome-study-network-neptune-to-evaluate-primary/)
- [Management of Childhood Onset Nephrotic Syndrome](https://scholariq.org/papers/management-of-childhood-onset-nephrotic-syndrome/)
- [IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome](https://scholariq.org/papers/ipna-clinical-practice-recommendations-for-the-diagnosis-and-management-of-2/)
- [A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis](https://scholariq.org/papers/a-phase-1-single-dose-study-of-fresolimumab-an-anti-tgf-antibody-in-treatment/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Adolescent and Pediatric Healthcare](https://scholariq.org/topics/adolescent-and-pediatric-healthcare/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.